David Ahern

2.1k total citations · 1 hit paper
16 papers, 930 citations indexed

About

David Ahern is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, David Ahern has authored 16 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in David Ahern's work include Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (3 papers). David Ahern is often cited by papers focused on Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (3 papers). David Ahern collaborates with scholars based in United Kingdom, Denmark and United States. David Ahern's co-authors include Fionula M. Brennan, Moustafa Attar, Neil Ashley, James Kinchen, Laura Cubitt, Felix Clemens Richter, Agne Antanaviciute, Kaushal Parikh, Marta Jagielowicz and Esther Mellado-Gomez and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

David Ahern

15 papers receiving 924 citations

Hit Papers

Structural Remodeling of the Human Colonic Mesenchyme in ... 2018 2026 2020 2023 2018 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Ahern United Kingdom 11 492 324 233 164 116 16 930
Vasiliki Koliaraki Greece 20 406 0.8× 414 1.3× 435 1.9× 110 0.7× 131 1.1× 38 1.3k
Cristiana Caorsi Italy 14 305 0.6× 306 0.9× 145 0.6× 75 0.5× 110 0.9× 20 762
Xianbo Zuo China 21 324 0.7× 391 1.2× 113 0.5× 169 1.0× 62 0.5× 95 1.0k
Yenkel Grinberg‐Bleyer France 15 966 2.0× 266 0.8× 345 1.5× 223 1.4× 139 1.2× 26 1.4k
Racquel Corpuz United States 10 395 0.8× 600 1.9× 314 1.3× 92 0.6× 208 1.8× 13 1.3k
Hirokazu Kurata Japan 12 731 1.5× 315 1.0× 230 1.0× 111 0.7× 65 0.6× 12 1.1k
Nicolas Poirier France 23 1.1k 2.2× 194 0.6× 223 1.0× 129 0.8× 249 2.1× 69 1.5k
Melvin M. Denis United States 8 231 0.5× 511 1.6× 149 0.6× 102 0.6× 104 0.9× 9 1.2k
Flora Coulon France 18 653 1.3× 202 0.6× 152 0.7× 74 0.5× 136 1.2× 28 1.0k
Olga Stasikowska‐Kanicka Poland 16 184 0.4× 234 0.7× 211 0.9× 53 0.3× 127 1.1× 72 749

Countries citing papers authored by David Ahern

Since Specialization
Citations

This map shows the geographic impact of David Ahern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ahern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ahern more than expected).

Fields of papers citing papers by David Ahern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ahern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ahern. The network helps show where David Ahern may publish in the future.

Co-authorship network of co-authors of David Ahern

This figure shows the co-authorship network connecting the top 25 collaborators of David Ahern. A scholar is included among the top collaborators of David Ahern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ahern. David Ahern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Baker, Warren L., et al.. (2023). Mass cytometry as a tool in target validation and drug discovery. Methods in enzymology on CD-ROM/Methods in enzymology. 690. 541–574. 1 indexed citations
3.
Sivakumar, Shivan, Enas Abu‐Shah, David Ahern, et al.. (2021). Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer. Cancers. 13(8). 1776–1776. 26 indexed citations
4.
Cribbs, Adam P., Martin Philpott, Jeroen Baardman, et al.. (2020). Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism. Proceedings of the National Academy of Sciences. 117(11). 6056–6066. 73 indexed citations
5.
Wang, Lihui, Zhichao Ai, Tariq Khoyratty, et al.. (2020). ROS-producing immature neutrophils in giant cell arteritis are linked to vascular pathologies. JCI Insight. 5(20). 65 indexed citations
7.
Sivakumar, Shivan, Enas Abu‐Shah, David Ahern, et al.. (2019). The T cell architecture of pancreatic ductal adenocarcinoma. Annals of Oncology. 30. iv64–iv64. 1 indexed citations
8.
Kinchen, James, Hannah H. Chen, Kaushal Parikh, et al.. (2018). Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease. Cell. 175(2). 372–386.e17. 450 indexed citations breakdown →
9.
Cole, Jennifer E., Inhye Park, David Ahern, et al.. (2018). Immune cell census in murine atherosclerosis: cytometry by time of flight illuminates vascular myeloid cell diversity. Cardiovascular Research. 114(10). 1360–1371. 122 indexed citations
10.
Pascal, Véronique, Andreas E. R. Fasth, Yvonne Sundström, et al.. (2014). Balance between activating NKG2D, DNAM‐1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts. Immunology. 142(4). 581–593. 35 indexed citations
11.
Bryant, Jane, David Ahern, & Fionula M. Brennan. (2012). CXCR4 and vascular cell adhesion molecule 1 are key chemokine/adhesion receptors in the migration of cytokine‐activated T cells. Arthritis & Rheumatism. 64(7). 2137–2146. 25 indexed citations
12.
Nielsen, Nikoline Juul, Elisabeth D. Galsgaard, David Ahern, et al.. (2012). FRI0020 Blocking the inhibitory CD94/NKG2A NK cell receptor with a novel ANTI-NKG2A MAB enhances the susceptibility of rheumatoid arthritis fibroblast-like synoviocytes (FLS) to NK cell-mediated cytotoxicity. Annals of the Rheumatic Diseases. 71. 316–316. 2 indexed citations
13.
Andersson, Anna, Percy F. Sumariwalla, Fiona E. McCann, et al.. (2011). Blockade of NKG2D ameliorates disease in mice with collagen‐induced arthritis: A potential pathogenic role in chronic inflammatory arthritis. Arthritis & Rheumatism. 63(9). 2617–2629. 44 indexed citations
14.
Ahern, David & Fionula M. Brennan. (2010). The role of Natural Killer cells in the pathogenesis of rheumatoid arthritis: Major contributors or essential homeostatic modulators?. Immunology Letters. 136(2). 115–121. 48 indexed citations
15.
Ahern, David, Clare M. Lloyd, & David S. Robinson. (2009). Chemokine responsiveness of CD4+ CD25+ regulatory and CD4+ CD25− T cells from atopic and nonatopic donors. Allergy. 64(8). 1121–1129. 17 indexed citations
16.
Ahern, David & Douglas S. Robinson. (2005). Regulatory T cells as a target for induction of immune tolerance in allergy. Current Opinion in Allergy and Clinical Immunology. 5(6). 531–538. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026